Stephens initiated coverage on Alignment Healthcare Inc (NASDAQ: ALHC), saying it offers growth-oriented small-cap investors pure-play exposure to Medicare Advantage (MA), a catalyst for sustained growth in Managed Care.
PMV Pharmaceuticals Inc (NASDAQ: PMVP) announced updated Phase 1 results from its ongoing Phase 1/2 PYNNACLE trial that showed PC14586 achieved efficacy in heavily pretreated patients across multiple tumor types and was well tolerated with a
Edesa Biotech Inc (NASDAQ: EDSA) has secured a commitment of up to C$23 million from the Government of Canada for a pivotal Phase 3 clinical study of the company's first-in-class therapeutic candidate.
QuidelOrtho Corporation (NASDAQ: QDEL) released preliminary Q3 revenue of $738 million to $744 million, primarily driven by higher respiratory product sales,
Eli Lilly And Co (NYSE: LLY) plans to submit a marketing application for a drug that treats Crohn's disease to the Food and Drug Administration (FDA) in 2024.